Bone Biologics Corporation Stock
Equities
BBLG
US0980705018
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | -18.13% | -38.26% | -68.58% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.6M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | -3 | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.34
x | P/E ratio 2025 * |
-0.38
x | Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.49% |
1 day | -0.19% | ||
1 week | -21.02% | ||
Current month | +16.33% | ||
1 month | +13.53% | ||
3 months | -42.33% | ||
6 months | -56.88% | ||
Current year | -59.81% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Frelick
CEO | Chief Executive Officer | 59 | 15-08-16 |
Deina Walsh
DFI | Director of Finance/CFO | 60 | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Stroever
BRD | Director/Board Member | 75 | 11-12-31 |
Don Hankey
CHM | Chairman | 81 | 18-07-15 |
Robert Gagnon
BRD | Director/Board Member | 49 | Jan. 07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.41 | -22.53% | 197 237 |
24-05-20 | 1.82 | -3.19% | 26,185 |
24-05-17 | 1.88 | -14.55% | 241,247 |
24-05-16 | 2.2 | -3.08% | 82,083 |
24-05-15 | 2.27 | -1.30% | 855,061 |
Delayed Quote Nasdaq, May 21, 2024 at 09:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.81% | 1.6M | |
+10.17% | 126B | |
-5.66% | 11.33B | |
+6.07% | 9.27B | |
+36.44% | 5.5B | |
-21.73% | 4.61B | |
+8.68% | 3.45B | |
-8.76% | 2.81B | |
-10.91% | 2.09B | |
-6.38% | 2.08B |
- Stock Market
- Equities
- BBLG Stock